Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2005
01/12/2005CN1561982A Bumetanide dripping pill and its preparing method
01/12/2005CN1561981A Sodium ferulate preparation and its preparing method
01/12/2005CN1561980A Melbine hydrochloride enteric coatel slow-releasing preparation and its preparing method
01/12/2005CN1561979A Micro capsule for choline chloride for ruminant stomach and its preparing method
01/12/2005CN1561978A Hexoprenaline hydrochloride dripping pill and its preparing method
01/12/2005CN1561977A Chlorpronaline hydrochloride dripping pill and its preparing method
01/12/2005CN1561976A Garlicin concentrated, solution for supply intravenous after composite solvent dilution
01/12/2005CN1561975A Use of central China fruit of Chinese magnoliavine ketone in preparing medicine for food for preventing and treating Alzheimer's disease
01/12/2005CN1561974A Medicinal composition containing cyclodextrin and phenylpropyl alcohol substance
01/12/2005CN1561973A External long-acting analgesic
01/12/2005CN1561970A Fat soluble vitamin freeze-drying emulsion and its preparing method
01/12/2005CN1561968A Antibody and polyalkylene glycol-bonded liposome
01/12/2005CN1561963A Enteric coatel material coated anti-inflammation agent insert layer hydrotalcite and its preparing method
01/12/2005CN1184321C Adenovirus-mediated gene therapy
01/12/2005CN1184229C Furost saponine analogue and its separation process and use
01/12/2005CN1184227C Prodn. method of avermectin compounds
01/12/2005CN1184221C New quinalidinic acid derivative with 7-(7-aminomethyl-5-azaspiro [2,4] heplane) substituent and its preparation method
01/12/2005CN1184219C Taxusane phoshponic oxygen methyl ether derivant
01/12/2005CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
01/12/2005CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators
01/12/2005CN1184209C Chuanxiong alkoxide derivative and its preparation and medicinal composition containing it and use thereof
01/12/2005CN1184208C Substituted benzimidazoles and their prepn. and use
01/12/2005CN1184204C Piperidine compounds for use as CCR-3 inhibitors
01/12/2005CN1184203C 1-benzyl-4-[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine
01/12/2005CN1184201C Method for producing one or more kinds of oxydic carotenoid dry powder
01/12/2005CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same
01/12/2005CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same
01/12/2005CN1183964C Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir
01/12/2005CN1183962C Preparation capable of mobilization of activity
01/12/2005CN1183958C Medicine for treating tummy bug
01/12/2005CN1183957C Chinese medicine capsules for treating phlebitis and angiitis
01/12/2005CN1183945C Medicine for treating urinary culculus
01/12/2005CN1183940C Ointment for curnig leukoplakia vulvae and its preparing method
01/12/2005CN1183929C Medicine for curing prolapse of lumbar intervertebral disc and its preparation method
01/12/2005CN1183917C Dermatosis treating ointment
01/12/2005CN1183915C Medicine preparation for inhibiting immune deficiency syndrome virus infection and proliferation and its application
01/12/2005CN1183914C Use of N-acetyl-D-aminoglucose in preparation of anti-tumor and anti-tumor-transition medicines
01/12/2005CN1183913C Application of N-acetyl-D-aminoglucose in preparing medicines to treat cardiac and cerebral ischemical and anoxia
01/12/2005CN1183912C Medicine for relieving itching and detumescence
01/12/2005CN1183911C Health-care medicine for improving vitality of old people and its prescription
01/12/2005CN1183910C Antibiotic medicine for injection
01/12/2005CN1183909C Medicine for dropping off drug and its preparing process
01/12/2005CN1183908C Injection medication combination of nimodiping and its preparing method
01/12/2005CN1183907C Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same
01/12/2005CN1183906C Preparation process for surfaceanesthesia cream
01/12/2005CN1183902C Process for preparing oral calcium compositions
01/12/2005CN1183900C Nicotine inhaler
01/12/2005CN1183895C Anhyrous aerosol hairspray compositions containing silicone grafted copolymers
01/11/2005US6841702 Arylguanidine derivatives; antimetastasis and antitumor agents
01/11/2005US6841698 Aminopropylphosphinic acids
01/11/2005US6841684 Imidiazoles having reduced side effects
01/11/2005US6841682 Prevent binding of adrenergenic receptors
01/11/2005US6841680 2-(Halophenyl)-quinoline derivatives for neuropathic pain; side effect reduction
01/11/2005US6841679 Acylation of 2-(phenyl)-imidazo(1,2-a)pyridine derivative with oxalyl halide derivative to form anxiolytic agent; reduction, salt formation
01/11/2005US6841678 Hofmann degradation of amide to amine
01/11/2005US6841674 N-heterocyclic derivatives as NOS inhibitors
01/11/2005US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
01/11/2005US6841662 Nucleotide sequences coding enzymatic polypeptide for use in the human dietics, cosmetics and therapeutics
01/11/2005US6841617 Thermogelling biodegradable aqueous polymer solution
01/11/2005US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers
01/11/2005US6841578 Administering a an inhibitor of nuclear factor-kappa B to an individual undergoing or preparing to undergo a treatment for cancer; particularly ulcerative mouth tissue; antiinflammatory agents; side effect reduction
01/11/2005US6841576 Anti-hypertensive composition and methods of treatment
01/11/2005US6841575 Fewer side and/or analgesic effects
01/11/2005US6841574 Topical stabilized prostaglandin E compound dosage forms
01/11/2005US6841573 Administering arachidonic acid to increase level of the prostaglandin PGF2alpha which is non-steroidal, and can increase protein synthesis and muscle mass
01/11/2005US6841572 Application of solutions of preservative acids or weakly alkaline preservative salts in a buffered acidic aqueous medium
01/11/2005US6841571 Compounds useful as reversible inhibitors of cysteine proteases
01/11/2005US6841569 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants
01/11/2005US6841568 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy
01/11/2005US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones
01/11/2005US6841566 Viral polymerase inhibitors
01/11/2005US6841565 Treatment of patients with chronic lymphocytic leukemia
01/11/2005US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors
01/11/2005US6841563 Aryloxy propanolamines for improving livestock production
01/11/2005US6841561 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
01/11/2005US6841558 Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors
01/11/2005US6841557 Compounds for the treatment of addictive disorders
01/11/2005US6841555 Lavendamycin analogs, quinoline-5,8-diones and methods of using them
01/11/2005US6841554 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
01/11/2005US6841553 Contorlling fertility
01/11/2005US6841551 Administering substance P receptor antagonist selected from the group consisting of L 742694, L 758298, and LY 303241, a non-toxic magnesium compound and a pharmaceutically acceptable vehicle
01/11/2005US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines
01/11/2005US6841548 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives
01/11/2005US6841547 Decreasing elevated serum/plasma low density lipoprotein-cholesterol levels and C-reactive protein levels by administering a tetracycline formulation
01/11/2005US6841546 Prevention of microorganismal infections; obtain sample of microorganism, incubate with tetracycline compound, monitor propagation of microorganism, reduced propagation indicates effective fungicide
01/11/2005US6841545 Heat resistance; anticancer drug
01/11/2005US6841544 Composition and method for treating the effects of diseases and maladies
01/11/2005US6841543 Contacting a human immune cell with a sufficient amount of a pharmaceutical composition consisting essentially of non-crosslinked, monovalent Lewisx antigen consisting of LNFP-III lacto-N-fucopentaose III
01/11/2005US6841539 Oligonucleotide admixed with a topical penetration enhancer, isopropyl myristate
01/11/2005US6841177 Pharmacological activities of curcuma longa extracts
01/11/2005US6841176 For increasing glutathione and antioxidant and antitoxin levels to achieve and maintain a health
01/11/2005US6841173 Selenium-compound (e.g., sodium selenite or selenate or selenomethionine); chondroitin sulfate; glucosamine; and methylsulfonylmethane.
01/11/2005US6841167 With oral bioavailability; tadalafil soft capsule
01/11/2005US6841162 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog
01/11/2005US6841161 Topical compositions
01/11/2005US6841146 Containing water, a drug and a mixture of microcrystalline cellulose and an alkali metal carboxyalkylcellulose
01/11/2005US6840244 Condom with an erectogenic composition
01/11/2005CA2369099C Anticonvulsant derivatives useful in reducing blood glucose levels
01/11/2005CA2369091C Anticonvulsant derivatives useful in lowering blood pressure
01/11/2005CA2284051C Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates